ABP 215 - HY-P99476
Nur noch %1 verfügbar
Catalog #
HY-P99476
ABP 215 (Bevacizumab-awwb), a Bevacizumab (Bevacizumab (HY-P9906)) biosimilar, is a humanized IgG1 monoclonal antibody targeting VEGFA (VEGFR). ABP 215 has anticancer effects, and can be used metastatic colorectal cancer (mCRC) research[1][2].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-P99476/ABP-215-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room temperature |
| Application | Cancer-Kinase/protease |
| CAS | 1438851-35-4 |
| MWT | N/A |
| Solubility | 10 mM in DMSO |
| Clinical Information | Phase 3 |
| Target | VEGFR |
| Application: | Cancer-Kinase/protease |
|---|